Esomeprazole magnesium
Pro Research Analysisby 
Searched over 200M research papers for "esomeprazole magnesium"
Esomeprazole Magnesium: Efficacy, Pharmacokinetics, and Safety
Efficacy in Duodenal Ulcer Treatment
Comparison of Esomeprazole Enteric-Coated Capsules and Esomeprazole Magnesium
Esomeprazole magnesium is widely used for treating duodenal ulcers. A study comparing esomeprazole enteric-coated capsules and esomeprazole magnesium (both 40 mg) found that both formulations were equally effective in healing duodenal ulcers. After two weeks, the ulcer healing rates were 86.7% for the enteric-coated capsules and 85.2% for the magnesium form, reaching 100% in both groups by the fourth week. Symptom relief was also comparable between the two groups, with no significant difference in adverse events, indicating similar safety profiles .
Pharmacokinetics and Bioequivalence
Bioequivalence in Healthy Subjects
Several studies have evaluated the pharmacokinetics and bioequivalence of esomeprazole magnesium. In healthy Chinese subjects, both generic and brand formulations of esomeprazole magnesium enteric-coated tablets (20 mg) were found to be bioequivalent under fasting and fed conditions. The pharmacokinetic parameters, including Cmax and AUC, fell within the acceptable bioequivalence range of 80-125%, and both formulations were well-tolerated with no serious adverse events 24.
Delayed-Release Formulations
A novel dual-release mini-tablet polycap formulation of esomeprazole magnesium was developed to address nocturnal acid breakthrough (NAB). This formulation showed a prolonged onset time and improved bioavailability compared to commercial products, making it a promising alternative for better dosing compliance and nighttime comfort .
Safety and Tolerability
General Safety Profile
Esomeprazole magnesium has been shown to be safe and well-tolerated in various studies. In trials assessing its bioequivalence, no severe adverse events were reported, and the safety profiles of test and reference formulations were similar 2410.
Impact on Antioxidant Capacity
Esomeprazole magnesium also appears to have beneficial effects on gut antioxidant capacity. In mice, it increased total antioxidant capacity and Cu/Zn-superoxide dismutase activity in the stomach, suggesting a potential role in reducing free radical production and enhancing antioxidant defenses in the gastrointestinal tract .
Special Considerations
Use in Pregnancy and Preeclampsia
Esomeprazole magnesium has been investigated for its potential use in treating preeclampsia. Both esomeprazole magnesium hydrate and trihydrate forms were effective in reducing key factors associated with preeclampsia, such as sFLT-1 secretion and endothelial dysfunction markers. However, the hydrate form was more efficacious in vitro, indicating its potential as a repurposed treatment for this serious obstetric condition .
Drug Interactions
When coadministered with ubrogepant, a migraine treatment, esomeprazole magnesium slightly reduced the peak plasma concentration of ubrogepant but did not significantly affect its overall pharmacokinetics. This interaction is likely to have limited clinical relevance, and no increase in adverse events was observed .
Conclusion
Esomeprazole magnesium is an effective and safe treatment for duodenal ulcers and other gastrointestinal conditions. Its pharmacokinetic properties and bioequivalence with other formulations make it a reliable option for patients. Additionally, its potential benefits in enhancing antioxidant capacity and treating preeclampsia highlight its versatility. Overall, esomeprazole magnesium remains a valuable therapeutic agent with a well-established safety profile.
Sources and full results
Most relevant research papers on this topic
Comparison of esomeprazole enteric-coated capsules vs esomeprazole magnesium in the treatment of active duodenal ulcer: a randomized, double-blind, controlled study.
Both esomeprazole enteric-coated capsules and esomeprazole magnesium effectively heal duodenal ulcers and relieve gastrointestinal symptoms, with comparable tolerability and safety.
Esomeprazole magnesium.
Esomeprazole magnesium inhibits gastric acid production by binding to H+/K+ ATPase, preventing acid secretion and promoting acid neutralization.
DOI